Oxaliplatin Injection

Form: Solution for Injection

Strength: 50 mg/10 mL, 100 mg/20 mL, 200 mg/40 mL

Reference Brands: Eloxatin(US & EU)

Category: Oncology Cancer Care

Oxaliplatin Injection is a platinum-based chemotherapeutic agent available in 50 mg, 100 mg, and 200 mg strengths for IV infusion. Widely used in the U.S. and EU, it is a key component of the FOLFOX regimen for the treatment of advanced and metastatic colorectal cancer. Oxaliplatin interferes with DNA replication, leading to cancer cell death. Approved for both adjuvant and palliative therapy, it plays a vital role in oncology B2B distribution. Available as a solution for infusion, Oxaliplatin supports effective cancer management and enhances treatment outcomes for colorectal cancer patients across global markets